# FRONTIDA BIOPHARM, LLC
> **Administrative - Formal** · FY2025 · — · Final Order With Penalty
## Case
- **Activity ID:** `3604372049`
- **Case Number:** 03-2025-0065
- **Type:** Administrative - Formal
- **Lead:** EPA
- **Outcome:** Final Order With Penalty
- **Penalty assessed:** —
- **Cost recovery:** —
- **Compliance action $:** —
- **Multimedia (multi-env):** —
## Defendants
- FRONTIDA BIOPHARM, LLC (complaint) (settlement)
## Summary

On April 21, 2025, EPA Region 3 filed an Expedited Settlement Agreement and Final Order, simultaneously commencing and concluding an administrative action proceeding against Frontida BioPharm, LLC located at 7722 Dungan Road in Philadelphia, PA 19111 ( Facility ) for violations of the Resource Conservation and Recovery Act ( RCRA ) and the authorized Pennsylvania Hazardous Waste Management Regulations, discovered during EPA's compliance evaluation inspection of the Facility on March 1, 2023.  Frontida BioPharm, LLC is a contract packager of prescription pharmaceutical solids, has notified as a Small Quantity Generator of hazardous waste, and generates flammable, corrosive, and spent solvent wastes. The violations in the settlement include operating without a permit, failure to make hazardous waste determinations, failure to conduct weekly inspections of waste accumulation area, failure to file an exception report, failure to document hazardous waste shipment on a manifest, and failure to manage universal waste lamps and batteries according to the regulations. Region 3 notified PADEP, which had no objections to this action.  Per the terms of the Expedited Settlement Agreement, the Facility will pay a civil penalty in the amount of $13,750.00. This action supports the Administrator's Pillar 1: Clean Air, Land, and Water for Every American.

---
*Source: [EPA ECHO](https://echo.epa.gov/) · AI Analytics · CC0 1.0*